The Development of ATM Inhibitors in Cancer Therapy is a research paper published in Targeted Oncology (2025). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: R35 GM119512
NCI NIH HHS
Grant: K22 CA273681
NIGMS NIH HHS
Grant: T32 GM132055
National Science Foundation Graduate Research Fellowship Program
Grant: 2024372992
American Cancer Society
Grant: CAT-24-1410062-01-CAT
Hollings Cancer Center, Medical University of South Carolina
Grant: Marti's Wish Award
Hollings Cancer Center, Medical University of South Carolina
Grant: Dr. Mark Green Young Investigator Award
Hollings Cancer Center, Medical University of South Carolina
Grant: Marti's Wish Award
National Institutes of Health
Grant: 5R35GM119512-04
Connecting BRCA1 functions with DNA crosslink sensitivity
National Institutes of Health
Grant: 5T32GM132055-05
Cellular, Biochemical and Molecular Sciences Training Program: Developing the skills and expertise needed for a changing biomedical landscape
National Institutes of Health
Grant: 5K22CA273681-03
DNA repair dysfunction in cancer induced by altered BRCA2 localization
Medical University of South Carolina
Fields of Study
MeSH Terms
Keywords